Systemic Lupus Erythematosus in Pregnancy
Abstract
1. Introduction
2. Materials and Methods
3. Results
3.1. The Selection Process of Included Studies
3.2. Effects of Pregnancy on Lupus
3.3. Effects of Pregnancy on Lupus
- Preterm birth: Preterm birth is considered the most common adverse outcome in SLE pregnancies, as it occurs in over a third of the cases [10,65]. Elevated lupus activity, even if only serological without clinical manifestations, inappropriate treatment with steroids (high prednisone use causes rupture of the placental membranes and acute fetal distress [18]), high blood pressure, thyroid disease [53], and severe renal failure might cause irregularities to the menstrual cycle, amenorrhea, and are the main contributors to a preterm birth [78].
- Preeclampsia: Preeclampsia is characterized by the pregnancy-specific induction of hypertension and proteinuria, which lead to significant end-organ damage, pregnancy losses, and IUGR, among others. Preeclampsia’s frequency is reported doubled to tripled in lupus pregnancies in comparison to healthy ones [19]. Preeclampsia resembles lupus nephritis (LN), presenting as a conundrum to differential diagnosis. Lupus nephritis is an inflammation of the kidneys and a result of SLE. Preeclampsia can also occur in healthy pregnancies and does not pose a threat of similar range. The distinction between the two lies upon the decreasing complement levels, increasing dsDNA antibody levels, and the urine sediment in LN. The prompt diagnosis is also critical, as a different approach is adopted in each case: delivery for preeclampsia (often depicted in study results as cesarean section) and immunosuppression for SLE [10]. We cannot rule out that the studies exploring LN/preeclampsia, which were included in our systematic review, were not biased against the differentiation between them; however, it is notable that at least a fifth of pregnancies are complicated by hypertension and/or proteinuria. In a comprehensive regional analysis, Cajamarca-Baron et al. [68] reported high rates of adverse outcomes, including preeclampsia (up to 52%) and preterm birth (up to 70%). The presence of lupus nephritis nearly doubled the risk of preeclampsia (RR = 1.89), underscoring the need for aggressive renal disease monitoring and tailored care in this population.
- Antiphospholipid antibodies (aPL): Antiphospholipid antibodies, i.e., anticardiolipin and lupus anticoagulant, are present in 25–50% of lupus pregnancies. The complications are attributed to thrombosis in the uterine vasculature, due to the inactivation of coagulation factors, as well as to the binding of antibodies to trophoblasts, endothelial, and neuronal cells. aPL antibodies are closely associated with IUGR and fetal morbidity, as a twofold increase in fetal loss is documented in comparison to aPL-negative pregnancies [12,26,50]. Notably, a few studies found no association between aPL antibodies and fetal loss [49].It is necessary to distinguish the presence of aPL antibodies from primary antiphospholipid syndrome (APS). aPL antibodies may occur without coexisting lupus, posing a risk to pregnancy. Factually, aPL presence without APS shows an elevated risk of APOs, like intrauterine growth retardation and preterm births [64].
3.4. Pregnancy Complications
3.5. Predictors of Pregnancy Outcomes
3.6. Disease Management
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
Abbreviation | Full Form |
SLE | Systemic lupus erythematosus |
LN | Lupus nephritis |
APO | Adverse pregnancy outcome |
NLS | Neonatal lupus syndrome |
aPL | Antiphospholipid antibodies |
CHB | Complete heart block |
NICU | Neonatal intensive care unit |
IUGR | Intrauterine growth restriction |
HELLPs | Hemolysis with elevated liver tests and low platelets |
HCQ | Hydroxychloroquine |
APS | Antiphospholipid syndrome |
ANAs | Anti-nuclear antibodies |
dsDNA | Double-stranded DNA |
Th1 | T helper 1 cells |
Th2 | T helper 2 cells |
IL-10 | Interleukin-10 |
IL-6 | Interleukin-6 |
hCG | Human chorionic gonadotropin |
PRL | Prolactin |
IVIg | Intravenous immunoglobulin |
RCTs | Randomized controlled trials |
NOS | Newcastle–Ottawa scale |
PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
PICOS | Population, Intervention, Comparison, Outcome, Study design |
RC | Retrospective cohort study |
PC | Prospective cohort study |
CC | Case–control study |
SRMA | Systematic review and meta-analysis |
References
- Carmona-Rivera, C.; Kaplan, M.J. Low-Density Granulocytes: A Distinct Class of Neutrophils in Systemic Autoimmunity. Semin. Immunopathol. 2013, 35, 455–463. [Google Scholar] [CrossRef]
- Branch, D.W. Physiologic Adaptations of Pregnancy. Am. J. Reprod. Immunol. 1992, 28, 120–122. [Google Scholar] [CrossRef] [PubMed]
- Cutolo, M.; Wilder, R.L. Different Roles for Androgens and Estrogens in the Susceptibility to Autoimmune Rheumatic Diseases. Rheum. Dis. Clin. N. Am. 2000, 26, 825–839. [Google Scholar] [CrossRef]
- Wilder, R.L. Hormones, Pregnancy, and Autoimmune Diseases. Ann. N. Y. Acad. Sci. 1998, 840, 45–50. [Google Scholar] [CrossRef] [PubMed]
- Lateef, A.; Petri, M. Systemic Lupus Erythematosus and Pregnancy. Rheum. Dis. Clin. N. Am. 2017, 43, 215–226. [Google Scholar] [CrossRef] [PubMed]
- Lim, S.S.; Drenkard, C. Epidemiology of Lupus: An Update. Curr. Opin. Rheumatol. 2015, 27, 427–432. [Google Scholar] [CrossRef]
- Alshohaib, S. Outcome of Pregnancy in Patients with Inactive Systemic Lupus Erythromatosus and Minimal Proteinuria. Saudi J. Kidney Dis. Transplant. 2009, 20, 802–805. [Google Scholar]
- Urowitz, M.B.; Gladman, D.D.; Farewell, V.T.; Stewart, J.; Mcdonald, J. Lupus and Pregnancy Studies. Arthritis Rheum. 1993, 36, 1392–1397. [Google Scholar] [CrossRef]
- Wagner, S.J.; Craici, I.; Reed, D.; Norby, S.; Bailey, K.; Wiste, H.J.; Wood, C.M.; Moder, K.G.; Liang, K.P.; Liang, K.V.; et al. Maternal and Foetal Outcomes in Pregnant Patients with Active Lupus Nephritis. Lupus 2009, 18, 342–347. [Google Scholar] [CrossRef]
- Clowse, M.E.B.; Jamison, M.; Myers, E.; James, A.H. A National Study of the Complications of Lupus in Pregnancy. Am. J. Obs. Gynecol. 2008, 199, 127.e1–127.e6. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, A.; Ibkhatra, S.; Elbraky, F.; Alsaeiti, K. Maternal and Fetal Outcomes in Patients with Systemic Lupus Erythematosus. Ibnosina J. Med. Biomed. Sci. 2020, 12, 33–37. [Google Scholar] [CrossRef]
- Al Arfaj, A.S.; Khalil, N. Pregnancy Outcome in 396 Pregnancies in Patients with SLE in Saudi Arabia. Lupus 2010, 19, 1665–1673. [Google Scholar] [CrossRef] [PubMed]
- Andrade, R.M.; McGwin, G.; Alarcón, G.S.; Sanchez, M.L.; Bertoli, A.M.; Fernández, M.; Fessler, B.J.; Apte, M.; Arango, A.M.; Bastian, H.M.; et al. Predictors of Post-Partum Damage Accrual in Systemic Lupus Erythematosus: Data from LUMINA, a Multiethnic US Cohort (XXXVIII). Rheumatology 2006, 45, 1380–1384. [Google Scholar] [CrossRef] [PubMed]
- Aydin, S.; Ersan, F.; Ark, C.; Aydin, Ç.A. Partial HELLP Syndrome: Maternal, Perinatal, Subsequent Pregnancy and Long-Term Maternal Outcomes. J. Obs. Gynaecol. Res. 2014, 40, 932–940. [Google Scholar] [CrossRef]
- Bertolaccini, M.L.; Mepani, K.; Sanna, G.; Hughes, G.R.V.; Khamashta, M.A. Factor XII Autoantibodies as a Novel Marker for Thrombosis and Adverse Obstetric History in Patients with Systemic Lupus Erythematosus. Ann. Rheum. Dis. 2007, 66, 533–536. [Google Scholar] [CrossRef] [PubMed]
- Brucato, A.; Doria, A.; Frassi, M.; Castellino, G.; Franceschini, F.; Faden, D.; Pia Pisoni, M.; Solerte, L.; Muscarà, M.; Lojacono, A.; et al. Pregnancy Outcome in 100 Women with Autoimmune Diseases and Anti-Ro/SSA Antibodies: A Prospective Controlled Study. Lupus 2002, 11, 716–721. [Google Scholar] [CrossRef]
- Buyon, J.P.; Kim, M.Y.; Guerra, M.M.; Laskin, C.A.; Petri, M.; Lockshin, M.D.; Sammaritano, L.; Branch, D.W.; Porter, T.F.; Sawitzke, A.; et al. Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. Ann. Intern. Med. 2015, 163, 153–163. [Google Scholar] [CrossRef]
- Cavallasca, J.A.; Laborde, H.A.; Ruda-Vega, H.; Nasswetter, G.G. Maternal and Fetal Outcomes of 72 Pregnancies in Argentine Patients with Systemic Lupus Erythematosus (SLE). Clin. Rheumatol. 2008, 27, 41–46. [Google Scholar] [CrossRef]
- Chakravarty, E.F.; Colón, I.; Langen, E.S.; Nix, D.A.; El-Sayed, Y.Y.; Genovese, M.C.; Druzin, M.L. Factors That Predict Prematurity and Preeclampsia in Pregnancies That Are Complicated by Systemic Lupus Erythematosus. Am. J. Obs. Gynecol. 2005, 192, 1897–1904. [Google Scholar] [CrossRef]
- Chen, S.; Sun, X.; Wu, B.; Lian, X. Pregnancy in Women with Systemic Lupus Erythematosus: A Retrospective Study of 83 Pregnancies at a Single Centre. Int. J. Environ. Res. Public Health 2015, 12, 9876. [Google Scholar] [CrossRef]
- Chandran, V.; Aggarwal, A.; Misra, R. Active Disease during Pregnancy Is Associated with Poor Foetal Outcome in Indian Patients with Systemic Lupus Erythematosus. Rheumatol. Int. 2005, 26, 152–156. [Google Scholar] [CrossRef] [PubMed]
- Clark, C.A.; Spitzer, K.A.; Nadler, J.N.; Laskin, C.A. Preterm Deliveries in Women with Systemic Lupus Erythematosus. J. Rheumatol. 2003, 30, 2127–2132. [Google Scholar] [PubMed]
- Clowse, M.E.B.; Magder, L.S.; Petri, M. The Clinical Utility of Measuring Complement and Anti-DsDNA Antibodies during Pregnancy in Patients with Systemic Lupus Erythematosus. J. Rheumatol. 2011, 38, 1012–1016. [Google Scholar] [CrossRef]
- Daskalakis, G.J.; Kontessis, P.S.; Papageorgiou, I.S.; Paraskevopoulos, A.P.; Digenis, G.E.; Karaiskakis, P.T.; Antsaklis, A.J.; Zerefos, N.S. Lupus Nephritis and Pregnancy. Hypertens. Pregnancy 1998, 17, 23–30. [Google Scholar] [CrossRef]
- Rokutanda, R.; Kishimoto, M.; Deshpande, G.A.; Yamaguchi, K.; Okada, M. Comment on Predictors of Preterm Birth in Patients with Mild Systemic Lupus Erythematosus by Clowse et Al. Ann. Rheum. Dis. 2013, 72, e2. [Google Scholar] [CrossRef]
- Cortes-Hernandez, J.; Ordi-Ros, J.; Paredes, F.; Casellas, M.; Castillo, F.; Vilardell-Tarres, M. Clinical Predictors of Fetal and Maternal Outcome in Systemic Lupus Erythematosus: A Prospective Study of 103 Pregnancies. Rheumatology 2002, 41, 643–650. [Google Scholar] [CrossRef] [PubMed]
- Derksen, R.H.; Bruinse, H.W.; de Groot, P.G.; Kater, L. Pregnancy in Systemic Lupus Erythematosus: A Prospective Study. Lupus 1994, 3, 149–155. [Google Scholar] [CrossRef]
- Eudy, A.M.; Siega-Riz, A.M.; Engel, S.M.; Franceschini, N.; Howard, A.G.; Clowse, M.E.B.; Petri, M. Effect of Pregnancy on Disease Flares in Patients with Systemic Lupus Erythematosus. Ann. Rheum. Dis. 2018, 77, 855–860. [Google Scholar] [CrossRef]
- Gaballa, H.A.; El-Shahawy, E.E.D.; Atta, D.S.; Gerbash, E.F. Clinical and Serological Risk Factors of Systemic Lupus Erythematosus Outcomes during Pregnancy. Egypt. Rheumatol. 2012, 34, 159–165. [Google Scholar] [CrossRef]
- Georgiou, P.E.; Politi, E.N.; Katsimbri, P.; Sakka, V.; Drosos, A.A. Outcome of Lupus Pregnancy: A Controlled Study. Rheumatology 2000, 39, 1014–1019. [Google Scholar] [CrossRef]
- Giancotti, A.; Spagnuolo, A.; Bisogni, F.; D’Ambrosio, V.; Pasquali, G.; Panici, P.B. Pregnancy and Systemic Lupus Erythematosus: Role of Ultrasound Monitoring. Eur. J. Obs. Gynecol. Reprod. Biol. 2011, 154, 233–234. [Google Scholar] [CrossRef]
- Huang, P.Z.; Du, P.Y.; Han, C.; Xia, J.; Wang, C.; Li, J.; Xue, F.X. Pre-Eclampsia with New-Onset Systemic Lupus Erythematosus during Pregnancy: A Case Report. World J. Clin. Cases 2019, 7, 3800. [Google Scholar] [CrossRef]
- Lê Thi Huong, D.; Wechsler, B.; Vauthier-Brouzes, D.; Beaufils, H.; Lefebvre, G.; Piette, J.C. Pregnancy in Past or Present Lupus Nephritis: A Study of 32 Pregnancies from a Single Centre. Ann. Rheum. Dis. 2001, 60, 599. [Google Scholar] [CrossRef]
- Lê Thi Huong, D.; Wechsler, B.; Vauthier-Brouzes, D.; Seebacher, J.; Lefèbvre, G.; Blétry, O.; Darbois, Y.; Godeau, P.; Piette, J.C. Outcome of Planned Pregnancies in Systemic Lupus Erythematosus: A Prospective Study on 62 Pregnancies. Br. J. Rheumatol. 1997, 36, 772–777. [Google Scholar] [CrossRef]
- Imbasciati, E.; Tincani, A.; Gregorini, G.; Doria, A.; Moroni, G.; Cabiddu, G.; Marcelli, D. Pregnancy in Women with Pre-Existing Lupus Nephritis: Predictors of Fetal and Maternal Outcome. Nephrol. Dial. Transpl. 2009, 24, 519–525. [Google Scholar] [CrossRef] [PubMed]
- Jaeggi, E.; Laskin, C.; Hamilton, R.; Kingdom, J.; Silverman, E. The Importance of the Level of Maternal Anti-Ro/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus a Prospective Study of 186 Antibody-Exposed Fetuses and Infants. J. Am. Coll. Cardiol. 2010, 55, 2778–2784. [Google Scholar] [CrossRef] [PubMed]
- Julkunen, H.; Jouhikainen, T.; Kaaja, R.; Teramo, K.; Leirisalo-Repo, M.; Stephansson, E.; Palosuop, T. Fetal Outcome in Lupus Pregnancy: A Retrospective Case-Control Study of 242 Pregnancies in 112 Patients. Lupus 1993, 2, 125–131. [Google Scholar] [CrossRef]
- Julkunen, H.; Kaaja, R.; Palosuo, T.; Grønhagen-Riska, C.; Teramo, K. Pregnancy in Lupus Nephropathy. Acta Obs. Gynecol. Scand. 1993, 72, 258–263. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.Y.; Lee, J.H. Prognosis of Neonates in Pregnant Women with Systemic Lupus Erythematosus. Yonsei Med. J. 2008, 49, 515. [Google Scholar] [CrossRef]
- Leaños-Miranda, A.; Cárdenas-Mondragón, G.; Ulloa-Aguirre, A.; Isordia-Salas, I.; Parra, A.; Ramírez-Peredo, J. Anti-Prolactin Autoantibodies in Pregnant Women with Systemic Lupus Erythematosus: Maternal and Fetal Outcome. Lupus 2007, 16, 342–349. [Google Scholar] [CrossRef]
- Liu, J.; Zhao, Y.; Song, Y.; Zhang, W.; Bian, X.; Yang, J.; Liu, D.; Zeng, X.; Zhang, F. Pregnancy in Women with Systemic Lupus Erythematosus: A Retrospective Study of 111 Pregnancies in Chinese Women. J. Matern. Fetal Neonatal Med. 2012, 25, 261–266. [Google Scholar] [CrossRef]
- Lockshin, M.D.; Reinitz, E.; Druzin, M.L.; Murrman, M.; Estes, D. Lupus Pregnancy. Case-Control Prospective Study Demonstrating Absence of Lupus Exacerbation during or after Pregnancy. Am. J. Med. 1984, 77, 893–898. [Google Scholar] [CrossRef] [PubMed]
- Mavragani, C.P.; Dafni, U.G.; Tzioufas, A.G.; Moutsopoulos, H.M. Pregnancy Outcome and Anti-Ro/SSA in Autoimmune Diseases: A Retrospective Cohort Study. Br. J. Rheumatol. 1998, 37, 740–745. [Google Scholar] [CrossRef]
- Mintz, G.; Niz, J.; Gutierrez, G.; Karchmer, S.; Garcia-Alonso, A. Prospective Study of Pregnancy in Systemic Lupus Erythematosus. Results of a Multidisciplinary Approach. Rheumatology 1996, 13, 732–739. [Google Scholar] [CrossRef]
- Mokbel, A.; Geilan, A.M.; AboElgheit, S. Could Women with Systemic Lupus Erythematosus (SLE) Have Successful Pregnancy Outcomes? Prospective Observational Study. Egypt. Rheumatol. 2013, 35, 133–139. [Google Scholar] [CrossRef]
- Molad, Y.; Borkowski, T.; Monselise, A.; Ben-Haroush, A.; Sulkes, J.; Hod, M.; Feldberg, D.; Bar, J. Maternal and Fetal Outcome of Lupus Pregnancy: A Prospective Study of 29 Pregnancies. Lupus 2005, 14, 145–151. [Google Scholar] [CrossRef]
- Moroni, G.; Quaglini, S.; Banfi, G.; Caloni, M.; Finazzi, S.; Ambroso, G.; Como, G.; Ponticelli, C. Pregnancy in Lupus Nephritis. Am. J. Kidney Dis. 2002, 40, 713–720. [Google Scholar] [CrossRef] [PubMed]
- Mosca, M.; Strigini, F.; Doria, A.; Pratesi, F.; Tani, C.; Iaccarino, L.; Chimenti, D.; Carmignani, A.; Cecchi, M.; Zampieri, S.; et al. Anti-C1q Antibodies in Pregnant Patients with Systemic Lupus Erythematosus. Clin. Exp. Rheumatol. 2007, 25, 449–452. [Google Scholar]
- Nossent, H.C.; Swaak, T.J.G. Systemic Lupus Erythematosus. VI. Analysis of the Interrelationship with Pregnancy. J. Rheumatol. 1990, 17, 771–776. [Google Scholar]
- Ogasawara, M.; Aoki, K.; Hayashi, Y. A Prospective Study on Pregnancy Risk of Antiphospholipid Antibodies in Association with Systemic Lupus Erythematosus. J. Reprod. Immunol. 1995, 28, 159–164. [Google Scholar] [CrossRef]
- Oviasu, E.; Hicks, J.; Cameron, J.S. The Outcome of Pregnancy in Women with Lupus Nephritis. Lupus 1991, 1, 19–25. [Google Scholar] [CrossRef]
- Petri, M.; Allbritton, J. Fetal Outcome of Lupus Pregnancy: A Retrospective Case-Control Study of the Hopkins Lupus Cohort. Reumatology 1993, 20, 650. [Google Scholar] [CrossRef]
- Rubbert, A.; Pirner, K.; Wildt, L.; Kalden, J.R.; Manger, B. Pregnancy Course and Complications in Patients with Systemic Lupus Erythematosus. Am. J. Reprod. Immunol. 1992, 28, 205–207. [Google Scholar] [CrossRef]
- Salazar-Páramo, M.; Jara, L.J.; Ramos, A.; Barile, L.; Machado, G.; García-De La Torre, I. Longitudinal Study of Antinuclear and Anticardiolipin Antibodies in Pregnant Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Rheumatol. Int. 2002, 22, 142–147. [Google Scholar] [CrossRef]
- Salomonsson, S.; Dörner, T.; Theander, E.; Bremme, K.; Larsson, P.; Wahren-Herlenius, M. A Serologic Marker for Fetal Risk of Congenital Heart Block. Arthritis Rheum. 2002, 46, 1233–1241. [Google Scholar] [CrossRef] [PubMed]
- Sittiwangkul, S.; Louthrenoo, W.; Vilhayasai, P.; Sukitawue, W. Pregnancy Outcome in Thai Patients with Systemic Lupus Erythematosus. Asian Pac. J. Allergy Immunol. 1999, 17, 77–83. [Google Scholar]
- Stagnaro-Green, A.; Akhter, E.; Yim, C.; Davies, T.F.; Magder, L.S.; Petri, M. Thyroid Disease in Pregnant Women with Systemic Lupus Erythematosus: Increased Preterm Delivery. Lupus 2011, 20, 690–699. [Google Scholar] [CrossRef] [PubMed]
- Spence, D.; Hornberger, L.; Hamilton, R.; Silverman, E.D. Increased Risk of Complete Congenital Heart Block in Infants Born to Women with Hypothyroidism and Anti-Ro and/or Anti-La Antibodies. J. Rheumatol. 2006, 33, 167–170. [Google Scholar]
- Surita, F.G.d.C.; Parpinelli, M.Â.; Yonehara, E.; Krupa, F.; Cecatti, J.G. Systemic Lupus Erythematosus and Pregnancy: Clinical Evolution, Maternal and Perinatal Outcomes and Placental Findings. Sao Paulo Med. J. 2007, 125, 91–95. [Google Scholar] [CrossRef] [PubMed]
- Tandon, A.; Ibañez, D.; Gladman, D.D.; Urowitz, M.B. The Effect of Pregnancy on Lupus Nephritis. Arthritis Rheum. 2004, 50, 3941–3946. [Google Scholar] [CrossRef]
- Tozman, E.C.; Urowitz, M.B.; Gladman, D.D. Systemic Lupus Erythematosus and Pregnancy. J. Rheumatol. 1980, 7, 624–632. [Google Scholar]
- Whitelaw, D.A.; Hall, D.; Kotze, T. Pregnancy in Systemic Lupus Erythematosus: A Retrospective Study from a Developing Community. Clin. Rheumatol. 2008, 27, 577–580. [Google Scholar] [CrossRef]
- Wong, K.L.; Chan, F.Y.; Lee, C.P. Outcome of Pregnancy in Patients With Systemic Lupus Erythematosus: A Prospective Study. Arch. Intern. Med. 1991, 151, 269–273. [Google Scholar] [CrossRef]
- Wong, C.H.; Chen, T.L.; Lee, C.S.; Lin, C.J.; Chen, C.P. Outcome of Pregnancy in Patients with Systemic Lupus Erythematosus. Taiwan. J. Obs. Gynecol. 2006, 45, 120–123. [Google Scholar] [CrossRef]
- Yuen, S.Y.; Krizova, A.; Ouimet, J.M.; Pope, J.E. Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) Is Improving: Results from a Case Control Study and Literature Review. Open Rheumatol. J. 2008, 2, 89–98. [Google Scholar] [CrossRef]
- Zhao, C.; Zhao, J.; Huang, Y.; Wang, Z.; Wang, H.; Zhang, H.; Xu, H.; Yang, N. New-Onset Systemic Lupus Erythematosus during Pregnancy. Clin. Rheumatol. 2013, 32, 815–822. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.; Zhou, Y.; Zhang, X.; Huang, C.; Liu, L.; Zhao, J.; Tian, X.; Li, M.; Zeng, X.; Zhao, Y.; et al. Risk and Protective Factors of Disease Flare during Pregnancy in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Clin. Rheumatol. 2025, 44, 887–899. [Google Scholar] [CrossRef] [PubMed]
- Cajamarca-Baron, J.; Sanmiguel-Reyes, C.; Bedoya-Loaiza, J.E.; Castañeda-Gonzalez, J.P.; Acelas-Gonzalez, G.E.; Molina-Giraldo, S.; Guavita-Navarro, D.; Ibáñez, C.; Escobar, A.; Rojas-Villarraga, A. Maternal and Fetal Outcomes in Latin American SLE Pregnancies: A Systematic Review and Meta-Analysis. Autoimmun. Rev. 2025, 24, 103744. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Liu, L.; Lin, S.; Duan, X.; Luo, H.; Wang, Y.; Wu, Z.; Huang, C.; Long, Y.; Cui, Y.; et al. The Conditions That Patients with Systemic Lupus Erythematosus Should Fulfill before Pregnancy to Optimize Outcomes: A Large-Scale Multicenter Cohort Study from China. Arthritis Res. Ther. 2025, 27, 31. [Google Scholar] [CrossRef]
- Wind, M.; Fierro, J.J.; Bloemenkamp, K.W.M.; de Leeuw, K.; Lely, A.T.; Limper, M.; Sueters, M.; Teng, Y.K.O.; Walter, I.J.; Kooiman, J. Pregnancy Outcome Predictors in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Lancet Rheumatol. 2024, 6, e667–e683. [Google Scholar] [CrossRef]
- Dai, Q.; Li, M.; Tian, X.; Song, Y.; Zhao, J. Predictive Factors for the Common Adverse Maternal and Fetal Outcomes in Pregnancies Complicated by Systemic Lupus Erythematosus. Womens Health Rep. New Rochelle 2024, 5, 434–443. [Google Scholar] [CrossRef]
- Zucchi, D.; Fischer-Betz, R.; Tani, C. Pregnancy in Systemic Lupus Erythematosus. Best Pract. Res. Clin. Rheumatol. 2023, 37, 101860. [Google Scholar] [CrossRef]
- Petri, M. The Hopkins Lupus Pregnancy Center: Ten Key Issues in Management. Rheum. Dis. Clin. N. Am. 2007, 33, 227–235. [Google Scholar] [CrossRef]
- Petri, M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. N. Am. 1997, 23, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Lima, F.; Buchanan, N.M.M.; Khamashta, M.A.; Kerslake, S.; Hughes, G.R.V. Obstetric Outcome in Systemic Lupus Erythematosus. Semin. Arthritis Rheum. 1995, 25, 184–192. [Google Scholar] [CrossRef] [PubMed]
- Ruiz-Irastorza, G.; Lima, F.; Alves, J.; Khamashta, M.A.; Simpson, J.; Hughes, G.R.V.; Buchanan, N.M.M. Increased Rate of Lupus Flare during Pregnancy and the Puerperium: A Prospective Study of 78 Pregnancies. Br. J. Rheumatol. 1996, 35, 133–138. [Google Scholar] [CrossRef]
- Langevitz, P.; Klein, L.; Pras, M.; Many, A. The Effect of Cyclophosphamide Pulses on Fertility in Patients with Lupus Nephritis. Am. J. Reprod. Immunol. 1992, 28, 157–158. [Google Scholar] [CrossRef]
- Mok, C.C.; Lau, C.S.; Wong, R.W.S. Use of Exogenous Estrogens in Systemic Lupus Erythematosus. Semin. Arthritis Rheum. 2001, 30, 426–435. [Google Scholar] [CrossRef] [PubMed]
- Juliao, P.; Wurst, K.; Pimenta, J.M.; Gemzoe, K.; Landy, H.; Moody, M.A.; Tilson, H.; Covington, D.; Moore, T.; Marino, R.; et al. Belimumab Use during Pregnancy: Interim Results of the Belimumab Pregnancy Registry. Birth Defects Res. 2022, 115, 188. [Google Scholar] [CrossRef]
Authors | Citation | Country | Type of Study | Number of Pregnancies | Study Population |
---|---|---|---|---|---|
Alshohaib, 2009 | [7] | UAE | PC | 20 | LN pregnancies |
Urowitz et al., 1993 | [8] | N/A | CC | N/A | SLE vs. non-SLE pregnancies |
Wagner et al., 2009 | [9] | USA | RC | N/A | SLE pregnancies |
Clowse et al., 2008 | [10] | USA | Comparative | 16.7 million | SLE vs. non-SLE pregnancies |
Ahmed et al., 2020 | [11] | Libya | RC | 60 | SLE pregnancies |
Al Arfaj and Khalil, 2010 | [12] | UAE | RC | 396 | Pre- and post-SLE pregnancies |
Andrade et al., 2006 | [13] | USA | RC | 63 | SLE pregnancies |
Aydin et al., 2014 | [14] | Turkey | Observational | N/A | HELPP individuals |
Bertolaccini et al., 2007 | [15] | England | CC | 123 | SLE vs. non-SLE pregnancies |
Brucato et al., 2002 | [16] | Italy | PC | 111 | Ro+ vs. Ro-SLE pregnancies |
Buyon et al., 2015 | [17] | USA and Canada | PC | 385 | SLE pregnancies |
Cavallasca et al., 2008 | [18] | Argentina | RC | 72 | SLE pregnancies |
Chakravarty et al., 2005 | [19] | USA | RC | 63 | SLE pregnancies |
Chen et al., 2015 | [20] | China | RC | 83 | SLE pregnancies |
Chandran et al., 2005 | [21] | India | RC | 52 | SLE pregnancies |
Clark et al., 2003 | [22] | Canada | RC | 88 | SLE pregnancies |
Clowse et al., 2011 | [23] | USA | RC | 267 | SLE pregnancies |
Daskalakis et al., 1998 | [24] | Greece | RC | 12 | SLE pregnancies |
Rokutanda et al., 2013 | [25] | USA | PC | 40 | SLE pregnancies |
Cortes-Hernandez et al., 2002 | [26] | Spain | PC | 103 | SLE pregnancies |
Derksen et al., 1994 | [27] | Holland | PC | 35 | SLE pregnancies |
Eudy et al., 2018 | [28] | USA | RC | 398 | SLE pregnancies |
Gaballa et al., 2012 | [29] | Egypt | PC | 40 | SLE vs. non-SLE pregnancies |
Georgiou et al., 2000 | [30] | UK | CC | 118 | SLE vs. non-SLE pregnancies |
Giancotti et al., 2011 | [31] | Italy | PC | 11 | SLE pregnancies |
Huang et al., 2019 | [32] | China | Case Report | 1 | SLE onset after pregnancy |
Lê Thi Huong et al., 2001 | [33] | France | PC | 116 | SLE pregnancies |
Lê Thi Huong et al., 1997 | [34] | France | PC | 62 | SLE pregnancies |
Imbasciati et al., 2009 | [35] | Italy | RC | 113 | LN pregnancies |
Jaeggi et al., 2010 | [36] | Canada | CC | 186 | Anti-Ro-positive pregnancies |
Julkunen et al., 1993 | [37] | Finland | Retrospective CC | 242 | SLE vs. non-SLE pregnancies |
Julkunen et al., 1993 | [38] | Finland | RC | 26 | SLE pregnancies |
Kim and Lee, 2008 | [39] | South Korea | CC | 105 | SLE vs. non-SLE pregnancies |
Leaños-Miranda et al., 2007 | [40] | Mexico | PC | 250 | SLE vs. non-SLE pregnancies |
Liu et al., 2012 | [41] | China | RC | 111 | SLE pregnancies |
Lockshin et al., 1984 | [42] | USA | Prospective CC | 144 | Antiphospholipid pregnancies |
Mavragani et al., 1998 | [43] | Greece | RC | 154 | Anti-Ro vs. non-SLE pregnancies |
Mintz et al., 1996 | [44] | N/A | PC | 102 | SLE pregnancies |
Mokbel et al., 2013 | [45] | Egypt | PC | 37 | SLE pregnancies |
Molad et al., 2005 | [46] | Israel | PC | 29 | SLE pregnancies |
Moroni et al., 2002 | [47] | Italy | RC | 70 | LN pregnancies |
Mosca et al., 2007 | [48] | Italy | PC | 21 | SLE pregnancies |
Nossent and Swaak, 1990 | [49] | Netherlands | CC | 63 | SLE vs. non-SLE pregnancies |
Ogasawara et al., 1995 | [50] | Japan | PC | 12 | SLE pregnancies |
Oviasu et al., 1991 | [51] | UK | RC | 53 | SLE pregnancies |
Petri and Allbritton, 1993 | [52] | USA | Retrospective CC | 1403 | SLE vs. non-SLE pregnancies |
Rubbert et al., 1992 | [53] | USA | Retrospective CC | 21 | SLE pregnancies vs. SLE individuals |
Salazar-Páramo et al., 2002 | [54] | Mexico | CC | 30 | SLE vs. non-SLE pregnancies |
Salomonsson et al., 2002 | [55] | Sweden | RC | 34 | Anti-Ro-positive pregnancies |
Sittiwangkul et al., 1999 | [56] | Thailand | RC | 48 | SLE pregnancies |
Stagnaro-Green et al., 2011 | [57] | USA | RC | 63 | SLE pregnancies |
Spence et al., 2006 | [58] | Canada | RC | 102 | SLE pregnancies |
Surita et al., 2007 | [59] | N/A | PC | N/A | SLE pregnancies |
Tandon et al., 2004 | [60] | Canada | Prospective CC | 156 | SLE pregnancies vs. healthy individuals |
Tozman et al., 1980 | [61] | N/A | RC | 24 | SLE pregnancies |
Whitelaw et al., 2008 | [62] | South Africa | RC | 47 | SLE pregnancies |
Wong et al., 1991 | [63] | N/A | PC | 29 | SLE pregnancies |
Wong et al., 2006 | [64] | Taiwan | RC | 24 | SLE pregnancies |
Yuen et al., 2008 | [65] | Canada | CC/Review | 242 | SLE pregnancies vs. healthy individuals |
Zhao et al., 2013 | [66] | China | RC | 48 | New-onset SLE in pregnancy |
Yang et al., 2025 | [67] | China | SRMA | N/A | SLE pregnancies across multiple global cohorts |
Cajamarca-Baron et al., 2025 | [68] | Latin America | SRMA | N/A | SLE pregnancies |
Zhang et al., 2025 | [69] | China | PC (multicenter) | 800 | SLE pregnancies |
Wind et al., 2024 | [70] | Netherlands | SRMA | N/A | SLE pregnancies |
Dai et al., 2024 | [71] | China | PC | 300 | SLE pregnancies |
Zucchi et al., 2023 | [72] | Italy, Germany | Review | N/A | SLE pregnancies |
Study | Selection (Max: 4) | Comparability (Max: 2) | Outcome-Exposure (Max: 3) | Total Score (Max: 9) | Comments | |
---|---|---|---|---|---|---|
Alshohaib, 2009 | [7] | 4 | 2 | 2 | 8 | Excellent methodological rigor with consistent adjustment for key factors |
Urowitz et al., 1993 | [8] | 4 | 2 | 2 | 8 | Exposure and outcome criteria clearly optimized |
Wagner et al., 2009 | [9] | 3 | 2 | 2 | 7 | Well-structured with minor concerns on follow-up and comparability |
Clowse et al., 2008 | [10] | 3 | 2 | 2 | 7 | Limited sample robustness; fair adjustment strategies |
Ahmed et al., 2020 | [11] | 3 | 1 | 2 | 6 | Adequate design with limited adjustments for confounding variables |
Al Arfaj and Khalil, 2010 | [12] | 3 | 1 | 2 | 6 | Acceptable structure, though lacking multicenter validation |
Andrade et al., 2006 | [13] | 3 | 2 | 2 | 7 | Robust framework; minor gaps in outcome follow-up |
Aydin et al., 2014 | [14] | 3 | 2 | 2 | 7 | Sound design with thorough comparability measures |
Bertolaccini et al., 2007 | [15] | 3 | 2 | 2 | 7 | Limited in sample diversity; exposure ascertainment is solid |
Brucato et al., 2002 | [16] | 3 | 1 | 2 | 6 | Lacks full confounder control; appropriate outcome definition |
Buyon et al., 2015 | [17] | 3 | 1 | 2 | 6 | Thorough assessment, though external generalizability could be improved |
Cavallasca et al., 2008 | [18] | 4 | 2 | 3 | 9 | Strong quality design; exceptional clarity in exposure/outcome tracking |
Chakravarty et al., 2005 | [19] | 3 | 1 | 2 | 6 | Confounding adjustment suboptimal; otherwise well-constructed |
Chen et al., 2015 | [20] | 3 | 1 | 2 | 6 | Exposure criteria adequate; limited scope in geographic population |
Chandran et al., 2005 | [21] | 3 | 1 | 2 | 6 | Simple but effective methodology; lacks longitudinal follow-up |
Clark et al., 2003 | [22] | 3 | 2 | 2 | 7 | Methodologically solid; some underreporting in control variables |
Clowse et al., 2011 | [23] | 3 | 1 | 2 | 6 | Strong internal validity; external replication needed |
Daskalakis et al., 1998 | [24] | 3 | 2 | 2 | 7 | Effective methods; lacks temporal control in exposure assessment |
Rokutanda et al., 2013 | [25] | 4 | 2 | 3 | 9 | Strong multicenter analysis with detailed outcome tracking |
Cortes-Hernandez et al., 2002 | [26] | 3 | 2 | 2 | 7 | Well-powered cohort; minor outcome documentation concerns |
Derksen et al., 1994 | [27] | 4 | 2 | 3 | 9 | Excellent cohort structure; rigorous adjustment practices |
Eudy et al., 2018 | [28] | 4 | 2 | 2 | 8 | Multicenter validation strengthens findings; strong confounder control |
Gaballa et al., 2012 | [29] | 3 | 1 | 2 | 6 | Strong statistical methodology; selection bias possible |
Georgiou et al., 2000 | [30] | 3 | 2 | 2 | 7 | Sample limitations reduce generalizability; otherwise, well-conceived |
Giancotti et al., 2011 | [31] | 4 | 2 | 3 | 9 | Very strong methodology, broad representativeness, and proper adjustment for confounders |
Huang et al., 2019 | [32] | 4 | 2 | 2 | 8 | Top-tier quality with proper comparator handling |
Lê Thi Huong et al., 2001 | [33] | 4 | 2 | 2 | 8 | Well-adjusted for bias; sample selection slightly limited |
Lê Thi Huong et al., 1997 | [34] | 3 | 2 | 2 | 7 | Well-structured with minor concerns on follow-up or comparability |
Imbasciati et al., 2009 | [35] | 3 | 2 | 2 | 7 | Well-structured with minor concerns on follow-up or comparability |
Jaeggi et al., 2010 | [36] | 4 | 2 | 2 | 8 | Careful exposure assessment; modest loss to follow-up |
Julkunen et al., 1993 | [37] | 3 | 1 | 2 | 6 | Methodology is clear; limited diversity in the sample |
Julkunen et al., 1993 | [38] | 3 | 1 | 2 | 6 | Clear methodology, but comparability is not fully addressed |
Kim and Lee, 2008 | [39] | 4 | 2 | 3 | 9 | Very strong methodology, broad representativeness, and proper adjustment for confounders |
Leaños-Miranda et al., 2007 | [40] | 3 | 1 | 2 | 6 | Moderate design limitations, single-center, and lacking comparability |
Liu et al., 2012 | [41] | 4 | 2 | 2 | 8 | Sound design with thorough comparability measures |
Lockshin et al., 1984 | [42] | 4 | 2 | 2 | 8 | Strong quality design; exceptional clarity |
Mavragani et al., 1998 | [43] | 4 | 2 | 2 | 8 | Excellent comparability design; generalizability is strong |
Mintz et al., 1996 | [44] | 3 | 1 | 2 | 6 | Appropriate structure; limited statistical depth |
Mokbel et al., 2013 | [45] | 4 | 2 | 3 | 9 | Transparent methods with robust validation procedures |
Molad et al., 2005 | [46] | 3 | 1 | 2 | 6 | Well-structured, minor limitations in selection |
Moroni et al., 2002 | [47] | 4 | 2 | 3 | 9 | Very strong methodology, broad representativeness, and proper adjustment for confounders |
Mosca et al., 2007 | [48] | 3 | 1 | 2 | 6 | Clear methodology, but comparability is not fully addressed |
Nossent and Swaak, 1990 | [49] | 4 | 2 | 2 | 8 | Single-center limits external validity; methods are reliable |
Ogasawara et al., 1995 | [50] | 4 | 2 | 2 | 8 | Very strong methodology, broad representativeness, and proper adjustment for confounders |
Oviasu et al., 1991 | [51] | 3 | 2 | 2 | 7 | Sufficiently powered but lacking external replication |
Petri and Allbritton, 1993 | [52] | 3 | 1 | 2 | 6 | Clear methodology, but comparability is not fully addressed |
Rubbert et al., 1992 | [53] | 3 | 1 | 2 | 6 | Modest design with adequate outcome specification |
Salazar-Páramo et al., 2002 | [54] | 3 | 2 | 2 | 7 | Sound overall, though it lacked in-depth comparator documentation |
Salomonsson et al., 2002 | [55] | 4 | 2 | 2 | 8 | Very strong methodology, broad representativeness, and proper adjustment for confounders |
Sittiwangkul et al., 1999 | [56] | 3 | 1 | 2 | 6 | The retrospective nature limits clarity |
Stagnaro-Green et al., 2011 | [57] | 3 | 2 | 2 | 7 | Well-structured with minor concerns on follow-up and comparability |
Spence et al., 2006 | [58] | 3 | 1 | 2 | 6 | Moderate design limitations, single-center, and lacking comparability |
Surita et al., 2007 | [59] | 4 | 2 | 3 | 9 | Very strong methodology, broad representativeness, and proper adjustment for confounders |
Tandon et al., 2004 | [60] | 4 | 2 | 2 | 8 | High reliability with well-structured outcome domains |
Tozman et al., 1980 | [61] | 4 | 2 | 3 | 9 | Excellent scoring across all NOS domains |
Whitelaw et al., 2008 | [62] | 4 | 2 | 2 | 8 | Very strong methodology, broad representativeness, and proper adjustment for confounders |
Wong et al., 1991 | [63] | 4 | 2 | 2 | 8 | Excellent methodological rigor with consistent adjustment for key factors |
Wong et al., 2006 | [64] | 3 | 2 | 2 | 7 | Sound overall, though it lacked in-depth comparator documentation |
Yuen et al., 2008 | [65] | 3 | 2 | 2 | 7 | Moderate design strength with acceptable bias control |
Zhao et al., 2013 | [66] | 3 | 1 | 2 | 6 | Reliable outcome documentation and exposure assessment, study groups show some baseline differences that may affect interpretation |
Yang et al., 2025 | [67] | 4 | 2 | 2 | 8 | Well-conducted with robust selection criteria and moderate uniformity in outcome measures, minor variability in exposure definitions |
Cajamarca-Baron et al., 2025 | [68] | 4 | 2 | 2 | 8 | Comprehensive meta-analysis with diverse sources, comparability criteria well met, but outcomes reported with some heterogeneity between studies |
Zhang et al., 2025 | [69] | 4 | 2 | 3 | 9 | High-quality, large-scale, with clear preconception metrics, strong follow-up integrity, detailed outcome classification, and generalizability enhanced by multicenter design |
Wind et al., 2024 | [70] | 4 | 2 | 2 | 8 | Well-structured use of inclusion parameters, comparability of predictors was well addressed, though outcome definitions varied slightly across studies |
Dai et al., 2024 | [71] | 4 | 2 | 3 | 9 | Strong predictor–outcome alignment and comprehensive adjustment for confounding variables, rigorous lab-based risk factor evaluation supports robustness |
Zucchi et al., 2023 | [72] | 2 | 1 | 2 | 5 | Lacks systematic methods or bias mitigation tools, limiting the reliability of its conclusions |
Adverse Pregnancy Outcome | No. of Studies Reporting APOs (n = 65) | % of Studies |
---|---|---|
Preterm birth | 34 | 52% |
Miscarriage | 29 | 45% |
Intrauterine growth restriction (IUGR) | 17 | 26% |
Stillbirth | 11 | 17% |
Low birth weight | 10 | 15% |
Neonatal death | 7 | 11% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gerede, A.; Oikonomou, E.; Stavros, S.; Potiris, A.; Papasozomenou, P.; Zafrakas, M.; Domali, E.; Nikolettos, N.; Eleutheriades, M. Systemic Lupus Erythematosus in Pregnancy. Med. Sci. 2025, 13, 174. https://doi.org/10.3390/medsci13030174
Gerede A, Oikonomou E, Stavros S, Potiris A, Papasozomenou P, Zafrakas M, Domali E, Nikolettos N, Eleutheriades M. Systemic Lupus Erythematosus in Pregnancy. Medical Sciences. 2025; 13(3):174. https://doi.org/10.3390/medsci13030174
Chicago/Turabian StyleGerede, Angeliki, Efthymios Oikonomou, Sofoklis Stavros, Anastasios Potiris, Panagiota Papasozomenou, Menelaos Zafrakas, Ekaterini Domali, Nikolaos Nikolettos, and Makarios Eleutheriades. 2025. "Systemic Lupus Erythematosus in Pregnancy" Medical Sciences 13, no. 3: 174. https://doi.org/10.3390/medsci13030174
APA StyleGerede, A., Oikonomou, E., Stavros, S., Potiris, A., Papasozomenou, P., Zafrakas, M., Domali, E., Nikolettos, N., & Eleutheriades, M. (2025). Systemic Lupus Erythematosus in Pregnancy. Medical Sciences, 13(3), 174. https://doi.org/10.3390/medsci13030174